2010Clinical ophthalmologyOpen access

Observation on the efficacy of using silicone nasolacrimal duct stent implantation for treating chronic dacryocystitis

Cheng Yi-non

Open full text 0 citations

Abstract

Objective To explore the efficacy of using the nasolacrimal duct stent implantation for treating nasolacrimal duct obstruction and chronic dacryocystitis. Methods First use silica gel to make nasolacrimal duct stent,then by nasal implantation and lacrimal duct treatment to treat 31 cases of nasal lacrimal duct obstruction and chronic dacryocystitis who were under general anesthesia in the nasal mucosa.Results The average follow-up after operation was seven months,and there were 26 cases (83.37%) who had epiphora symptom removed,and acrimal duct patency washe,2 cases (6.45%) who still had epiphora symptom but lacrimal duct patency washed,total effective rate was 90.32%. Conclusion Silicone nasolacrimal duct stent implantation is an effective way to treat nasolacrimal duct obstruction and chronic dacryocystitis.

About this research paper

What this paper is about

Objective To explore the efficacy of using the nasolacrimal duct stent implantation for treating nasolacrimal duct obstruction and chronic dacryocystitis. Methods First use silica gel to make nasolacrimal duct stent,then by nasal implantation and lacrimal duct treatment to treat 31 cases of nasal lacrimal duct obstruction and chronic dacryocystitis who were under general anesthesia in the nasal mucosa.Results The average follow-up after operation was seven months,and there were 26 cases (83.37%) who had epiphora symptom removed,and acrimal duct patency washe,2 cases (6.45%) who still had epiphora symptom but lacrimal duct patency washed,total effective rate was 90.32%. Conclusion Silicone nasolacrimal duct stent implantation is an effective way to treat nasolacrimal duct obstruction and chronic dacryocystitis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the efficacy of using the nasolacrimal duct stent implantation for treating nasolacrimal duct obstruction and chronic dacryocystitis. Methods First use silica gel to make nasolacrimal duct stent,then by nasal implantation and lacrimal duct treatment to treat 31 cases of nasal lacrimal duct obstruction and chronic dacryocystitis who were under general anesthesia in the nasal mucosa.Results The average follow-up after operation was seven months,and there were 26 cases (83.37%) who had epiphora symptom removed,and acrimal duct patency washe,2 cases (6.45%) who still had epiphora symptom but lacrimal duct patency washed,total effective rate was 90.32%. Conclusion Silicone nasolacrimal duct stent implantation is an effective way to treat nasolacrimal duct obstruction and chronic dacryocystitis.

Key concepts: Medicine, Chronic dacryocystitis, Nasolacrimal duct, Lacrimal duct, Nasolacrimal duct obstruction, Stent, Dacryocystitis, Surgery

Related papers

Back to paper searchBrowse research topicsOriginal source
Observation on the efficacy of using silicone nasolacrimal duct stent implantation for treating chronic dacryocystitis — Research Paper | ScholarLens